Danaher

Yahoo Finance • 22 hours ago

Morgan Stanley Initiates Coverage Of Veracyte, Inc. (VCYT)

Veracyte, Inc. (NASDAQ:VCYT) is among the 12 Best Genomics Stocks to Invest In.Morgan Stanley Initiates Coverage Of Veracyte, Inc. (VCYT) The Fly reported on December 2, 2025, that Morgan Stanley began covering Veracyte, Inc. (NASDAQ:VCYT... Full story

Yahoo Finance • 10 days ago

Goldman Sachs and KeyBanc are Bullish on Danaher (DHR)

Danaher Corporation (NYSE:DHR) is one of the 14 Best Large Cap Stocks to Invest In Now. On December 9, Goldman Sachs started covering Danaher Corporation (NYSE:DHR), giving the stock a Buy rating and setting the price target at $265. The... Full story

Yahoo Finance • 16 days ago

Is It Time To Consider Buying Danaher Corporation (NYSE:DHR)?

Today we're going to take a look at the well-established Danaher Corporation (NYSE:DHR). The company's stock led the NYSE gainers with a relatively large price hike in the past couple of weeks. The recent rally in share prices has nudged t... Full story

Yahoo Finance • 19 days ago

Martin Zweig Detailed Fundamental Analysis - DHR

Below is Validea's guru fundamental report for DANAHER CORP (DHR). Of the 22 guru strategies we follow, DHR rates highest using our Growth Investor model based on the published strategy of Martin Zweig. This strategy looks for growth stoc... Full story

Yahoo Finance • 21 days ago

Is Danaher Stock Still Attractive After Its Recent 9.1% Price Jump?

If you have been wondering whether Danaher at around $230 a share is a bargain in disguise or a quality name priced for perfection, you are not alone. This breakdown is designed to give you a clear, calm answer. Over the last month the sto... Full story

Yahoo Finance • 23 days ago

In Vitro Diagnostic Quality Control Market: Strategy & Trends with Forecasts by Assay Type, by Place, by Product, by Manufacturer and by Country - Situation Analysis with Executive & Consultant Guides

Dublin, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The "In Vitro Diagnostic Quality Control Market: Strategy & Trends with Forecasts by Assay Type, by Place, by Product, by Manufacturer and by Country - Situation Analysis with Executive & Consult... Full story

Yahoo Finance • 27 days ago

Morgan Stanley Ups the Ante on These 2 Life Science Tool Stocks

The broad healthcare sector accounts for roughly one-fifth of the U.S. economy and continues to expand. While most attention tends to go to the direct-care segment, the life-sciences industry is an equally critical pillar of the system. It... Full story

Yahoo Finance • 27 days ago

Danaher Stock Earns Relative Strength Rating Upgrade

Danaher stock had its Relative Strength (RS) Rating upgraded from 68 to 72 Thursday — a welcome improvement, but still shy of the 80 or higher score you prefer to see. When To Sell Stocks To Lock In Profits And Minimize Losses IBD's unique... Full story

Yahoo Finance • 28 days ago

Jim Cramer Says “Danaher’s Been Acting Much Better”

Danaher Corporation (NYSE:DHR) is one of the stocks Jim Cramer recently discussed. Cramer noted that he still likes the stock for the Charitable Trust, as he said: “Now, first, there’s tried and true, but lately trying Danaher, DHR, a con... Full story

Yahoo Finance • 30 days ago

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Albemarle, Circle Internet, Cloudflare, Danaher, Inspire Medical, Six Flags, Workday and More

mezzotint / Shutterstock.com Quick Read December trading started off with a “risk off” session on Monday, with all major indices ending the day lower. After another year of double-digit gains for stocks, investors are clearly ready to ta... Full story

Yahoo Finance • last month

GILD Named A Top Socially Responsible Dividend Stock

Gilead Sciences Inc (Symbol: GILD) has been named a Top Socially Responsible Dividend Stock by Dividend Channel, signifying a stock with above-average ''DividendRank'' statistics including a strong 4.9% yield, as well as being recognized b... Full story

Yahoo Finance • last month

Buffer Preparation Market Trends & Forecasts Report 2025-2035 Featuring Asahi Kasei, Avantor, Canvax, Danaher, GE, HOPAX, Merck, Prepared Biologics, Sartorius, Sepragen, Thermo Fisher Scientific, ZETA

Company Logo Key opportunities in the buffer preparation market include expanding demand for advanced buffer systems in biopharma production, increasing preference for outsourcing to reduce costs, and growth potential in reusable equipmen... Full story

Yahoo Finance • last month

North America Mass Spectrometry Market Report 2025-2033, Profiles of Agilent Technologies, Bruker, Danaher, Hitachi, JEOL, LECO, PerkinElmer, and Thermo Fisher Scientific

Company Logo The North America Mass Spectrometry Market is poised to surge from US$ 2.6 Billion in 2024 to US$ 4.87 Billion by 2033, driven by a 7.21% CAGR. Key growth areas include pharmaceutical, environmental analysis, and food safety... Full story

Yahoo Finance • last month

North America Nucleic Acid Amplification Testing Market Analysis Report 2025-2033 - Technological Advances, Rising Diagnostic Demand, and Widespread Applications

Company Logo The North American Nucleic Acid Amplification Testing (NAAT) market will reach $7.64 billion by 2033, growing from $3.28 billion in 2024 with a CAGR of 9.87%. Driven by technological advances, rising diagnostic demand, and wi... Full story

Yahoo Finance • last month

Danaher (DHR): Evaluating the Stock’s Current Valuation After Recent Gains

Danaher (DHR) stock has seen modest movement over the past month, gaining 3%. In contrast, the past three months marked a steadier 11% climb. Investors are weighing recent performance against the company’s longer-term trends. See our late... Full story

Yahoo Finance • last month

DHR Factor-Based Stock Analysis - Martin Zweig

Below is Validea's guru fundamental report for DANAHER CORP (DHR). Of the 22 guru strategies we follow, DHR rates highest using our Growth Investor model based on the published strategy of Martin Zweig. This strategy looks for growth stoc... Full story

Yahoo Finance • last month

US STD Diagnostics Market Forecast and Company Analysis 2025-2033 Featuring Abbott, F. Hoffmann-La Roche, Hologic, BD and Co, Danaher, Siemens, bioMerieux, Thermo Fisher Scientific, Qiagen, Bio-Rad

Company Logo The United States STD Diagnostics Market is set to grow from US$ 5.06 billion in 2024 to US$ 8.49 billion by 2033, achieving a CAGR of 5.91% from 2025 to 2033. Key growth drivers include rising STD prevalence, technological a... Full story

Yahoo Finance • 2 months ago

Akre Capital Management's Strategic Move: Significant Increase in Fair Isaac Corp Holdings

This article first appeared on GuruFocus. Insight into Akre Capital Management (Trades, Portfolio)'s Third Quarter 2025 Investment Moves Warning! GuruFocus has detected 3 Warning Signs with BABA. Is MA fairly valued? Test your thesis wit... Full story

Yahoo Finance • 2 months ago

IDBS announces i3 2026-An exclusive customer and partner event on data management innovation in BioPharma

WOKING, United Kingdom, Nov. 12, 2025 /PRNewswire/ -- Following the success of i3 2025, IDBS, a Danaher company and leading provider of cloud software for BioPharma companies, is excited to announce that its flagship customer and partner e... Full story

Yahoo Finance • 2 months ago

2 Healthcare Stocks for Individual Investors With a 40-Year Time Horizon

Key Points A biotech upstart and a life sciences giant could be compelling additions to an investor's portfolio. NovoCure is a high-risk but potentially high-reward bet on industry-changing technology. Danaher has faced some headwinds to... Full story